UCB, betting on seizure cell therapy, to buy Neurona for up to $1.2B
UCB→Neurona Therapeutics
Apr 17, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
Medical Technology Associates announced an add-on acquisition of Stat Biomedical, LLC to expand biomedical equipment services accessibility. The deal is framed as increasing access to biomedical equipment services.
Stat Biomedical is the acquired entity, and Medical Technology Associates is the buyer. The transaction is described as part of Medical Technology Associates’ broader biomedical equipment services offering.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
UCB→Neurona Therapeutics
Apr 17, 2026
Jackson Memorial Hospital
Apr 17, 2026
Kailera Therapeutics
Apr 17, 2026
Gilead→Arcellx
Apr 17, 2026
Panthera Biopartners→OEC
Apr 17, 2026